Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
MRE11A
REST API REST API
Homo sapiens
MRE11A is differentially expressed in 283 experiments: 130 organism parts: thymus, lung, ... (128 more);, 208 disease states: normal, prostate carcinoma, ... (206 more);, 85 cell types 364 cell lines 34 compound treatments and 71 other conditions.
Synonyms MRE11, ATLD
Orthologs Mre11a (Mus musculus)   E1BIN9_BOVIN (Bos taurus)   Mre11a (Rattus norvegicus)   ENSCING00000004996 (Ciona intestinalis)   mre11a (Danio rerio)   ENSCING00000011661 (Ciona intestinalis)   MRE11 (Saccharomyces cerevisiae)   F1N9H0_CHICK (Gallus gallus)   ENSCING00000015559 (Ciona intestinalis)   mre11 (Drosophila melanogaster)   mre11a (Xenopus laevis)   Q5SBJ0_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term chromosome, telomeric region, condensed nuclear chromosome, reciprocal meiotic recombination, DNA binding, double-strand break repair via homologous recombination, double-strand break repair via nonhomologous end joining, protein binding, DNA repair, nuclear chromatin, double-stranded DNA binding, nuclease activity, cell proliferation, Mre11 complex, 3'-5' exonuclease activity, meiosis, double-strand break repair, DNA duplex unwinding, sister chromatid cohesion, nucleus, ATP-dependent DNA helicase activity, manganese ion binding, heart development, endodeoxyribonuclease activity, DNA recombination, synapsis, perinuclear region of cytoplasm, hydrolase activity, endonuclease activity, protein C-terminus binding, nucleoplasm, cell cycle checkpoint, response to DNA damage stimulus, exonuclease activity, chromosome organization, DNA metabolic process, regulation of mitotic recombination, telomere maintenance via telomerase, negative regulation of DNA endoreduplication, positive regulation of kinase activity, single-stranded DNA specific endodeoxyribonuclease activity, positive regulation of protein autophosphorylation
InterPro Term DNA_repair, Mre11_DNA-bd, Metallo_PEstase_dom
UniProt Accession P49959, B3KTC7, Q9BS79, F5GXT0, F5H256, F5H742, F8W7U8
Gene-Disease Assocation ATAXIA-TELANGIECTASIA-LIKE DISORDER; ATLD
Search EB-eye ENSG00000020922
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-MEXP-1251, E-MTAB-24, E-MTAB-25, ... (20 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, ... (42 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-5823, E-GEOD-19639, E-GEOD-20081
HL-60
2
E-MTAB-37, E-GEOD-24147
BT-474
2
E-GEOD-5823, E-GEOD-3529
SW480
2
E-MEXP-1014, E-MTAB-37
BT474
1
2
E-MEXP-440, E-MTAB-37, E-MTAB-62
SNU449
1
E-MTAB-37
358 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-19397, E-GEOD-3920, E-GEOD-4219, E-GEOD-13909, ... (43 experiments)

Factor Value U/D Experiments
epithelial cell
2
E-MEXP-2034, E-GEOD-4483
monocyte
1
2
E-MEXP-583, E-GEOD-8286, E-GEOD-22373
eNK cell
1
E-GEOD-20499
hematopoietic
1
E-GEOD-9894
mesenchymal stem cell
1
E-GEOD-9894
iPSC derived from hASC using minicircle reprogramming vector
1
E-GEOD-20033
79 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-TABM-15, E-GEOD-16363, ... (57 experiments)

Factor Value U/D Experiments
prostate carcinoma
4
E-MEXP-2034, E-MTAB-37, E-MTAB-62, E-GEOD-96
dermatomyositis
3
E-GEOD-5370, E-GEOD-1551, E-MTAB-62
myeloma
3
E-MTAB-62, E-MTAB-372, E-MTAB-37
cervical carcinoma
3
E-MTAB-62, E-MEXP-1331, E-MTAB-37
lung adenocarcinoma
3
E-MTAB-37, E-MTAB-62, E-GEOD-2514
melanoma
2
E-MTAB-62, E-MTAB-37
202 more value(s).


Compound treatment

studied in E-GEOD-697, E-TABM-782, E-GEOD-3720, E-GEOD-5824, E-TABM-868, ... (25 experiments)

Factor Value U/D Experiments
none
5
8
E-GEOD-5824, E-TABM-868, E-GEOD-412, E-GEOD-20719, E-GEOD-4600, ... (13 experiments)
phoshate buffered saline
1
E-GEOD-3720
TNF
1
E-GEOD-15205
glutamine
1
E-MEXP-941
2-(3,4,5-trimethoxy-phenylamino)-pyrrolo[2,3-d]pyrimidines
1
1
E-GEOD-6932
NaOH
1
E-MEXP-2590
28 more value(s).


Age at diagnosis

studied in E-GEOD-3494

Factor Value U/D Experiments
28
2
1
E-GEOD-3494


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-860, E-MEXP-1251, ... (10 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-5999, E-GEOD-1614, E-GEOD-20033, E-GEOD-3140, E-MEXP-2359, ... (7 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743, E-TABM-147

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (10 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-3494, E-GEOD-2466, E-GEOD-17476, E-MEXP-421, ... (12 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-20504, E-MEXP-1446, E-GEOD-19018, E-GEOD-9764, E-GEOD-10315, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-740, E-GEOD-1926, E-MEXP-2069, ... (27 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, E-GEOD-980 ... (5 experiments)

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Pcr vs rd
studied in E-GEOD-20194, E-GEOD-16716

Performer
studied in E-GEOD-2004

Phenotype
studied in E-GEOD-7819, E-GEOD-19703, E-GEOD-22309, E-GEOD-21750, E-GEOD-1657, ... (8 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

Replicate
studied in E-GEOD-10797

RNAi
studied in E-MEXP-2115, E-MEXP-1509, E-GEOD-1676, E-MEXP-101, E-MEXP-548, ... (8 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400, E-GEOD-18995 ... (5 experiments)

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Treatment
studied in E-MEXP-973, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4271

Vehicle
studied in E-GEOD-5258

Processing time: 0.412 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM